The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
Uranium Energy Corp
DUS:U6Z
|
CA |
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
MY |
|
E
|
Engtex Group Bhd
KLSE:ENGTEX
|
MY |
|
E
|
Evd Bhd
KLSE:EVD
|
MY |
|
I
|
Infrastrutture Wireless Italiane SpA
F:WI8
|
IT |
|
OceanFirst Financial Corp
NASDAQ:OCFC
|
US |
|
F
|
FrieslandCampina Engro Pakistan Ltd
KAR:FCEPL
|
PK |
|
K
|
Kelly Services Inc
NASDAQ:KELYB
|
US |
|
Neometals Ltd
ASX:NMT
|
AU |
|
Pulmuone Co Ltd
KRX:017810
|
KR |
|
Cerus Corp
NASDAQ:CERS
|
US |
|
Flameret Inc
OTC:FLRE
|
US |
|
Piscines Desjoyaux SA
F:DJX
|
FR |
|
I
|
IDIS Holdings Co Ltd
KOSDAQ:054800
|
KR |
|
Var Energi ASA
F:J4V
|
NO |
|
ImExHS Ltd
ASX:IME
|
AU |
|
Agat Ejendomme A/S
CSE:AGAT
|
DK |
|
Acumen Pharmaceuticals Inc
NASDAQ:ABOS
|
US |
|
T
|
Tipco Foods PCL
SET:TIPCO
|
TH |
|
CMX Gold & Silver Corp
OTC:CXXMF
|
CA |
Uranium Energy Corp (U6Z)’s 12-month stock price forecast through October 2027 has a consensus target of €15.038, implying 114% upside. The forecast is based on price targets from 11 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for U6Z is 15.038 EUR with a low forecast of 9.927 EUR and a high forecast of 25.097 EUR.
Over the last 14 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 44%.
Over the last 14 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 4 years is 92%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more